Lyell Immunopharma
Lyell Immunopharma
lyell.com

Locations

South San Francisco, CA, USA

industry

Biotechnology

Size

201-1000 employees

Stage

Series C+

founded in

2018

Using living cells to treat – and sometimes even cure – cancer is one of the most dramatic advances in modern medicine. Patients with hematologic malignancies have been successfully treated with cell therapies. However, these profound results have not yet been achieved in patients with solid tumors, representing approximately 90% of all cancers. At Lyell, our goal is to change that. We are a clinical-stage T-cell reprogramming company advancing a diverse pipeline of cell therapies for solid tumors based on our innovative technologies. We were founded by cell therapy pioneers whose decades of research elevated the broader understanding of T-cell biology and its interaction with cancer. In our quest to defeat solid tumors, we have built a fully integrated company capable of discovering new technologies, translating science into therapies, manufacturing cell therapy products, and clinically evaluating them in patients. Our culture is based on science, respect, collaboration, and courage.

Something looks off?
Open jobs at Lyell Immunopharma
This company does not have jobs relevant to this job board at this time.
To view all their jobs, visit their website.